Innovative ETFs ChannelAn Outperforming ETF for a Post-Coronavirus Pandemic WorldBy Max ChenAugust 27, 2020
Multi-Factor ChannelHow to Gain Exposure to the Next Generation of HealthcareBy Max ChenAugust 26, 2020
Innovative ETFs ChannelBiotech ETFs Rally as ‘Operation Warp Speed’ Fuels Covid-19 ResearchBy Max ChenJuly 7, 2020
Innovative ETFs ChannelBiotech ETFs Rally After Inovio Locks in DOD Coronavirus DealBy Max ChenJune 23, 2020
Disruptive Technology ChannelWhy ETF Investors Should Consider Allocating to InnovationBy Max ChenMay 14, 2020
Disruptive Technology ChannelMaking the Case for Innovation: Rethinking Traditional Asset AllocationBy Max ChenMay 13, 2020
Equity ETF ChannelHealth Care Sector ETFs May Not Be so Defensive This Time AroundBy Max ChenMay 1, 2020
Tactical Allocation ChannelHealthcare ETFs Strengthen on Hopes of Combating CoronavirusBy Max ChenMarch 30, 2020
Disruptive Technology ChannelA Q&A with Trusted Experts to Help Clarify the UncertaintyBy Max ChenMarch 26, 2020
Disruptive Technology ChannelArtificial Intelligence is Helping Doctors Track the CoronavirusBy Ben HernandezMarch 9, 2020
Disruptive Technology ChannelETFs to Tap into Disruptive Technologies That Can Revolutionize the WorldBy Max ChenMarch 2, 2020
Disruptive Technology ChannelA Targeted Biotech ETF Is Brushing Off the SellingBy Max ChenFebruary 27, 2020
